GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,929,985 | -21.2% | 588,410 | +7.7% | 0.11% | -4.3% |
Q2 2023 | $2,448,589 | -7.1% | 546,560 | 0.0% | 0.12% | -19.6% |
Q1 2023 | $2,634,419 | +54.0% | 546,560 | 0.0% | 0.14% | +21.2% |
Q4 2022 | $1,710,732 | -3.9% | 546,560 | 0.0% | 0.12% | -6.3% |
Q3 2022 | $1,781,000 | -9.5% | 546,560 | 0.0% | 0.13% | -17.6% |
Q2 2022 | $1,967,000 | -12.0% | 546,560 | 0.0% | 0.15% | +7.7% |
Q1 2022 | $2,236,000 | -24.7% | 546,560 | 0.0% | 0.14% | -16.5% |
Q4 2021 | $2,968,000 | -27.1% | 546,560 | 0.0% | 0.17% | -37.7% |
Q3 2021 | $4,069,000 | -25.6% | 546,560 | 0.0% | 0.27% | -20.4% |
Q2 2021 | $5,466,000 | -33.0% | 546,560 | 0.0% | 0.34% | -39.6% |
Q1 2021 | $8,155,000 | – | 546,560 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
CM Management, LLC | 90,000 | $489,000 | 0.37% |
Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
Veritable, L.P. | 25,064 | $136,000 | 0.00% |
Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
MORGAN STANLEY | 800 | $4,000 | 0.00% |